XML 40 R34.htm IDEA: XBRL DOCUMENT v3.25.3
Organization, Basis of Presentation and Liquidity - Schedule of Lineage's Ownership of Outstanding Shares of its Subsidiaries (Details)
9 Months Ended
Sep. 30, 2025
Cell Cure Neurosciences Ltd. ("CCN") [Member]  
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]  
Field of business description Manufacturing of Lineage’s product candidates [1]
Ownership percentage by parent 94.00% [1]
ES Cell International Pte. Ltd. ("ESI") [Member]  
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]  
Field of business description Research and clinical grade cell lines
Ownership percentage by parent 100.00%
[1] Includes shares owned by Lineage and ESI.